Stay updated on Ociperlimab, Tislelizumab, Chemotherapy in Metastatic NSCLC Clinical Trial

Sign up to get notified when there's something new on the Ociperlimab, Tislelizumab, Chemotherapy in Metastatic NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ociperlimab, Tislelizumab, Chemotherapy in Metastatic NSCLC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Recruitment status has changed to not recruiting participants, and the record history has been updated with a new v3.6.0 entry while removing the previous v3.5.5 entry.
    Difference
    0.3%
    Check dated 2026-06-14T03:27:31.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The page history now records a new platform release version, Revision: v3.5.5, replacing the previous Revision: v3.5.4. This indicates an underlying system update rather than changes to the study details displayed on the page.
    Difference
    0.1%
    Check dated 2026-06-06T18:47:17.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    The Record History now lists the latest revision as v3.5.4, replacing the previous v3.5.3. This reflects an update to the record's metadata without changing the underlying study data.
    Difference
    0.1%
    Check dated 2026-05-16T09:20:19.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    The page’s displayed UI revision label was updated from v3.5.2 to v3.5.3, reflecting a software/version change rather than a change to the underlying clinical trial record.
    Difference
    0.1%
    Check dated 2026-04-24T16:50:07.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    A new revision entry v3.5.2 was added. The existing revision entry v3.5.0 was removed.
    Difference
    0.1%
    Check dated 2026-04-17T13:45:39.000Z thumbnail image
  7. Check
    98 days ago
    Change Detected
    Summary
    Revision history now includes v3.5.0; the v3.4.3 entry was removed.
    Difference
    0.1%
    Check dated 2026-03-19T20:42:42.000Z thumbnail image

Stay in the know with updates to Ociperlimab, Tislelizumab, Chemotherapy in Metastatic NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ociperlimab, Tislelizumab, Chemotherapy in Metastatic NSCLC Clinical Trial page.